Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Cedars-Sinai investigators create new blood test for early detection of common liver cancer

Cedars-Sinai investigators create new blood test for early detection of common liver cancer

Breast MRI may help stratify the risk of second breast cancer

Breast MRI may help stratify the risk of second breast cancer

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

Chinese researchers identify a new molecular mechanism of NASH pathogenesis

Chinese researchers identify a new molecular mechanism of NASH pathogenesis

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Celebrating 10 Years of Global Research with Breast Cancer Now Tissue Bank

Celebrating 10 Years of Global Research with Breast Cancer Now Tissue Bank

Scientists identify new driver for rare type of liver cancer

Scientists identify new driver for rare type of liver cancer

Study contributes to better understanding of the changes in kinase activity in renal cell carcinoma

Study contributes to better understanding of the changes in kinase activity in renal cell carcinoma

Machine learning models can predict posttreatment recurrence in patients with early-stage hepatocellular carcinoma

Machine learning models can predict posttreatment recurrence in patients with early-stage hepatocellular carcinoma

What is the association between polyfluoroalkyl substance exposure and risk of non-viral hepatocellular carcinoma?

What is the association between polyfluoroalkyl substance exposure and risk of non-viral hepatocellular carcinoma?

Study uncovers how common genetic mutations cause renal cancer

Study uncovers how common genetic mutations cause renal cancer

Exposure to a synthetic “forever chemical” linked to non-viral hepatocellular carcinoma

Exposure to a synthetic “forever chemical” linked to non-viral hepatocellular carcinoma

Study compares the nodule management protocols used in NELSON and National Lung Cancer Screening Trial

Study compares the nodule management protocols used in NELSON and National Lung Cancer Screening Trial

Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy

Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

Extracellular vesicle-based surface protein assay likely to lead to a better way to detect early-stage hepatocellular carcinoma

Study pinpoints a three-pronged approach that makes liver cancer cells stop growing

Study pinpoints a three-pronged approach that makes liver cancer cells stop growing

Experiments and mathematical modeling help study the role of morphogens in tissue patterning

Experiments and mathematical modeling help study the role of morphogens in tissue patterning

Novel targeted therapy may be an effective treatment option for neuroblastoma

Novel targeted therapy may be an effective treatment option for neuroblastoma

Transplant remains the standard of care for liver cancer patients, regardless of age

Transplant remains the standard of care for liver cancer patients, regardless of age

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.